Department of Gynaecology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François-Rabelais University, 10 boulevard Tonnelé, BP 3223, 37032 Tours cedex, France.
Department of Gynaecology, Centre Hospitalier Régional Universitaire de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France.
J Gynecol Obstet Hum Reprod. 2023 Jun;52(6):102600. doi: 10.1016/j.jogoh.2023.102600. Epub 2023 May 5.
Mastectomy is still a common treatment for breast cancer. The introduction of the Enhanced Recovery After Surgery pathway (ERAS) having proven its benefits for major surgeries has not yet been validated for mastectomy without reconstruction. Our study was conducted to investigate the effects of implementing an ERAS pathway for mastectomies, including the length of hospital stay, postoperative complications and patient satisfaction.
The study population included all patients who underwent mastectomy without immediate breast reconstruction in the gynecological surgery department of the Tours University Hospital during the year 2020. We compared patients who underwent an ERAS protocol with those who were managed in a standard manner.
Of the 92 patients managed for mastectomy, 32 were managed in the ERAS group. The two groups were comparable. We found fewer postoperative complications with this protocol in multivariate analysis. We also obtained a 37% response rate to the satisfaction questionnaires. We did not find any significant difference between the 2 groups.
There is a trend towards a decrease in the length of hospitalization associated with a decrease in postoperative complications thanks to the implementation of a ERAS protocol for the management of mastectomies. Future studies should focus on both objective clinical outcomes and patient-reported experiences to provide a comprehensive understanding of the effectiveness of ERAS protocols in mastectomy patients.
乳房切除术仍然是治疗乳腺癌的常见方法。虽然手术康复加速管理(ERAS)方案已被证明对大型手术有益,但尚未在不进行重建的乳房切除术中得到验证。我们的研究旨在探讨实施 ERAS 方案对乳房切除术的影响,包括住院时间、术后并发症和患者满意度。
研究人群包括 2020 年图尔大学医院妇科手术部门接受乳房切除术且未立即进行乳房重建的所有患者。我们比较了接受 ERAS 方案和常规管理的患者。
在 92 例接受乳房切除术的患者中,32 例接受 ERAS 组治疗。两组患者在各方面均具有可比性。多变量分析显示,该方案的术后并发症更少。我们还获得了 37%的满意度问卷回复率。两组之间没有发现显著差异。
由于实施了 ERAS 方案来管理乳房切除术,住院时间缩短,术后并发症减少。未来的研究应关注客观的临床结局和患者报告的体验,以全面了解 ERAS 方案在乳房切除术患者中的有效性。